IQ-AI Limited Share Price BOERSE MUENCHEN
Equities
5Y1
JE00BD4H0R42
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0215 EUR | -.--% | -.--% | -60.19% |
23/05 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
20/05 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
Sales 2022 | 5L 7L 6L 5.69Cr | Sales 2023 | 6L 8L 7L 6.48Cr | Capitalization | 89.62L 1.14Cr 1.05Cr 95Cr |
---|---|---|---|---|---|
Net income 2022 | - 0 0 0 | Net income 2023 | - 0 0 0 | EV / Sales 2022 | 5.75 x |
Net cash position 2022 | 3L 3L 3L 2.68Cr | Net cash position 2023 | 1L 2L 2L 1.47Cr | EV / Sales 2023 | 14.5 x |
P/E ratio 2022 |
-6.52
x | P/E ratio 2023 |
-13.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.72% |
1 month | +72.00% | ||
3 months | -18.87% | ||
6 months | -57.00% | ||
Current year | -60.19% |
Managers | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 13/15/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Brown
CEO | Chief Executive Officer | 78 | 13/15/13 |
Vinod Kaushal
BRD | Director/Board Member | 60 | 20/17/20 |
Director/Board Member | - | 18/19/18 |
Date | Price | Change |
---|---|---|
31/24/31 | 0.0215 | -.--% |
30/24/30 | 0.0215 | -.--% |
29/24/29 | 0.0215 | -.--% |
28/24/28 | 0.0215 | -.--% |
27/24/27 | 0.0215 | -.--% |
Real-time BOERSE MUENCHEN, May 01, 2024 at 01:14 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-24.16% | 776.06Cr | |
+68.65% | 433.23Cr | |
-2.98% | 264.08Cr | |
+2.72% | 263.49Cr | |
-46.17% | 216.15Cr | |
-15.27% | 175.09Cr | |
-22.12% | 146.25Cr | |
+13.62% | 117.04Cr | |
-43.81% | 114.45Cr |
- Stock Market
- Equities
- IQAI Stock
- 5Y1 Stock